Geron News (NASDAQ:GERN)
| Latest Geron News Headlines | | Date | Time | Source | | | 05/22/2007 | 11:57AM | PRNUS | BullMarket.com Updates Outlooks on Stem Cell Companies
PRINCETON, N.J., May 22 /PRNewswire/ -- BullMarket.com (http://www.bullmarket.com/), an online investment newsletter focused on long- term growth and income-generating stocks, announced today that it has provided subscribers with a detailed report updating outlooks on stem cell companies including Geron (NASDAQ:GERN... More...>> |
| 04/10/2007 | 9:00AM | PRNUS | Start Licensing Grants License Rights to GTC Biotherapeutics
AUSTIN, Texas, April 10 /PRNewswire/ -- Start Licensing, Inc. ("Start") announced today that it has granted GTC Biotherapeutics, Inc. (NASDAQ:GTCB) a non-exclusive license to Roslin Institute patents and patent applications. These applications include the foundational somatic cell nuclear transfer cloning technology... More...>> |
| 01/22/2007 | 8:30AM | PRNUS | MaxCyte Technology Licensed for Use in Geron's Cancer Vaccines
GAITHERSBURG, Md., Jan. 22 /PRNewswire/ -- MaxCyte, Inc. announced today that Geron Corporation (NASDAQ:GERN) has exercised an option for a clinical and commercial license to use MaxCyte's proprietary cell loading system in the manufacture of mRNA-loaded autologous dendritic cell-based vaccines, including Geron's GRNVAC1... More...>> |
| 03/07/2006 | 8:00AM | PRNUS | The Bull Market Report Publishes In-Depth Report on Stem Cell Companies
PRINCETON, N.J., March 7 /PRNewswire/ -- The Bull Market Report (http://www.bullmarket.com/), an online investment newsletter focused on long- term growth and income-generating stocks, announced that it has published an in-depth report on biotech companies focused on stem cell research, including Geron (NASDAQ:GERN... More...>> |
| 09/19/2005 | 9:52AM | PRNUS | MORNING UPDATE: Seven Summits Research issues alerts for MCD, NKE, GERN, APOL, and GILD
CHICAGO, Sept. 19 /PRNewswire/ -- Seven Summits Research issues the following Morning Update at 8:30 AM EDT with new PriceWatch Alerts for key stocks.
Before the open... PriceWatch Alerts for MCD, NKE, GERN, APOL, and GILD, Market Overview, News leaders and Laggards, Today's Economic Calendar, and the Quote Of The... More...>> |
| 04/20/2005 | 6:00AM | PRNUS | Transgenomic Inc. Continues to Provide Specialty Nucleic Acid Products to Geron Corporation
Transgenomic Inc. Continues to Provide Specialty Nucleic Acid
Products to Geron Corporation
Ongoing Support for Manufacture of Geron's Novel Cancer Therapeutic
OMAHA, Neb., April 20 /PRNewswire-FirstCall/ -- Transgenomic Inc.
(NASDAQ:TBIO) announced today it has agreed to provide additional quantities of
modified nucleic... More...>> |
| 01/18/2005 | 8:30AM | PRNUS | Cambrex Licenses Powerful Technologies for Conditionally Immortalized Cells For Use in Drug Discovery
Cambrex Licenses Powerful Technologies for Conditionally
Immortalized Cells For Use in Drug Discovery
EAST RUTHERFORD, N.J., Jan. 18 /PRNewswire-FirstCall/ -- Cambrex Corporation
(NYSE:CBM) is pleased to announce that its subsidiary Cambrex Bio Science
Wokingham, Ltd. has signed an agreement for the purchase of conditionally
immortalized... More...>> |
| 01/05/2005 | 9:40AM | PRNUS | MORNING UPDATE: Man Securities Inc. issues alerts for DELL, KKD, ET, CAL, and GERN
MORNING UPDATE: Man Securities Inc. issues alerts for DELL, KKD,
ET, CAL, and GERN
CHICAGO, Jan. 5 /PRNewswire/ -- Man Securities issues the following Morning
Update at 8:30 AM EST with new PriceWatch Alerts for key stocks.
(Logo: http://www.newscom.com/cgi-bin/prnh/20020214/MANSECLOGO )
Before the open... PriceWatch... More...>> |
| 04/28/2004 | 6:00AM | PRNUS | Transgenomic Inc. Continues to Provide Specialty Nucleic Acid Products to Geron Corporation
Transgenomic Inc. Continues to Provide Specialty Nucleic Acid
Products to Geron Corporation
Ongoing Support for Manufacture of Geron's Novel Cancer Therapeutic
OMAHA, Neb., April 28 /PRNewswire-FirstCall/ -- Transgenomic Inc. announced
today it has agreed to provide additional quantities of modified nucleic acid
building... More...>> |
| 03/18/2004 | 10:30AM | PRNUS | Advanced Cell Technology Announces Decision on Preliminary Motions in Patent Interference Proceeding
Advanced Cell Technology Announces Decision on Preliminary Motions in Patent
Interference Proceeding
WORCESTER, Mass., March 18 /PRNewswire/ -- Advanced Cell Technology, Inc. (ACT)
announced today that the Board of Patent Appeals and Interferences of the U.S.
Patent and Trademark Office has issued a decision in favor... More...>> |
|
|
|